Status:
COMPLETED
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
Lead Sponsor:
Daiichi Sankyo
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A comparison of 2 different combinations of high blood pressure medications to treat hypertension
Eligibility Criteria
Inclusion
- Greater than 18 years of age
- Patients with high blood pressure
Exclusion
- Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
- History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
- Type 1 diabetes mellitus
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00185120
Start Date
September 1 2005
End Date
September 1 2006
Last Update
January 18 2012
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Mobile, Alabama, United States, 36693
2
Memorial Research Medical Center
Long Beach, California, United States, 90806
3
National Research Institute
Los Angeles, California, United States, 90057
4
Clinical Trials Research
Roseville, California, United States, 95661